Journal Home
Search for

Volume 64, Issue 6, Pages 461-467 (15 September 2008)


View previous. 10 of 24 View next.

Subcallosal Cingulate Gyrus Deep Brain Stimulation for Treatment-Resistant Depression

Andres M. LozanoaCorresponding Author Informationemail address, Helen S. Maybergbc, Peter Giacobbeb, Clement Hamania, R. Cameron Craddockc, Sydney H. Kennedyb

Received 4 April 2008; received in revised form 26 May 2008; accepted 31 May 2008. published online 21 July 2008.

Background

A preliminary report in six patients suggested that deep brain stimulation (DBS) of the subcallosal cingulate gyrus (SCG) may provide benefit in treatment-resistant depression (TRD). We now report the results of these and an additional 14 patients with extended follow-up.

Methods

Twenty patients with TRD underwent serial assessments before and after SCG DBS. We determined the percentage of patients who achieved a response (50% or greater reduction in the 17-item Hamilton Rating Scale for Depression [HRSD-17]) or remission (scores of 7 or less) after surgery. We also examined changes in brain metabolism associated with DBS, using positron emission tomography.

Results

There were both early and progressive benefits to DBS. One month after surgery, 35% of patients met criteria for response with 10% of patients in remission. Six months after surgery, 60% of patients were responders and 35% met criteria for remission, benefits that were largely maintained at 12 months. Deep brain stimulation therapy was associated with specific changes in the metabolic activity localized to cortical and limbic circuits implicated in the pathogenesis of depression. The number of serious adverse effects was small with no patient experiencing permanent deficits.

Conclusions

This study suggests that DBS is relatively safe and provides significant improvement in patients with TRD. Subcallosal cingulate gyrus DBS likely acts by modulating brain networks whose dysfunction leads to depression. The procedure is well tolerated and benefits are sustained for at least 1 year. A careful double-blind appraisal is required before the procedure can be recommended for use on a wider scale.

a Division of Neurosurgery, University of Toronto, Toronto, Canada

b Department of Surgery, and Department of Psychiatry, University of Toronto, Toronto, Canada

c Department of Psychiatry, Emory University, Atlanta, Georgia

Corresponding Author InformationAddress reprint requests to Andres M. Lozano, M.D., Ph.D., Professor and RR Tasker Chair, Division of Neurosurgery, Toronto Western Hospital, Room 4-447, 399 Bathurst Street, Toronto, Ontario M5T2S8, Canada

PII: S0006-3223(08)00703-8

doi:10.1016/j.biopsych.2008.05.034


View previous. 10 of 24 View next.